Target intelligence / Profile preview

Long intergenic non-protein coding RNA 577 (LIN28B-AS1)

Target
LIN28B-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Cancer-testis long non-coding RNA (CT-lncRNA), Other (lncRNA, not protein-coding)
01

Overview

LIN28B-AS1 is a long non-coding RNA that regulates gene expression post-transcriptionally, mainly by stabilizing protein-coding mRNAs (notably LIN28B) through interaction with RNA-binding proteins like IGF2BP1. This lncRNA acts as a "scaffold," facilitating the targeting and stabilizing of oncogenic transcripts and promoting cell proliferation, migration, invasion, and resistance to apoptosis in cancer cells—particularly in hepatocellular carcinoma and lung adenocarcinoma. While not a traditional therapeutic target, LIN28B-AS1 is a key regulatory molecule in the cancer-testis lncRNA family, and holds promise as a biomarker and future therapeutic target for lncRNA-directed approaches.

Other names
LIN28B antisense RNA 1LIN28B-AS1dJ439I14.1C6orf220LINC00577long intergenic non-protein coding RNA 577
02

Mechanism of action

For potential drugs: Disruption or silencing of LIN28B-AS1 (using siRNA, antisense oligonucleotides, small molecules) could destabilize LIN28B mRNA and reduce oncogenic phenotypes. For indirect effectors: Curcumin attenuates chemoresistance by inhibiting NF-κB-induced LIN28B expression.

03

Biological functions

Stabilization of target mRNA (LIN28B) by acting as a scaffold for RNA-binding proteins (e.g., IGF2BP1)Promotion of cell proliferationInhibition of apoptosisEnhancement of cell migration and invasionRegulation of gene expression post-transcriptionallyParticipation in DNA damage repair and genome instability (through LIN28B pathway)Other (scaffolding of protein complexes regulating mRNAs)
04

Disease associations

Cancer, with strong evidence in hepatocellular carcinomaCancer-testis gene involvement (LUAD - Lung adenocarcinoma)Possible roles in other solid tumors (indirect, through LIN28B regulation)Other (oncogenesis-related processes)
05

Safety considerations

Therapeutic silencing of lncRNAs such as LIN28B-AS1 may face challenges of delivery, off-target effects, and immune activationThe specificity of ASO/siRNA approaches targeting lncRNAs is currently a major therapeutic hurdleUnknown long-term safety for lncRNA-directed interventions
06

Interacting drugs

No approved drugs are documented to directly target LIN28B-AS1 as of current literature

1 more in the full profile.

07

Biomarkers

LIN28B-AS1 expression is a candidate biomarker for aggressive cancer phenotype and prognosis in hepatocellular carcinoma and possibly LUADLevels may indicate IGF2BP1-mediated mRNA stability (e.g., Gli1, Myc, IGF2)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 577 (LIN28B-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 577 (LIN28B-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call